Anti Infective
Anti-Infective is a Therapy Area (TA) that covers over 11.8% revenue of the total Indian Pharmaceutical Market (IPM).
Alkem is No.1 in anti-infective TA with a wide range of medicines that fight against different kinds of infections.
Alkem has expertise in a wide range of formulations that include tablets, dry syrups and sterile dosage forms. Alkem controls 12.9%* of the total anti-infective Therapy Area (TA) of the Indian Pharmaceutical Market (IPM).
From the outset, brand building has been the greatest strength of Alkem. This has helped us become the only company with 9 anti-infective brands featuring amongst the top 300 brands of Indian Pharmaceutical Market. This has played a key role in propelling Alkem to the summit of anti-infective TA.
Some of the highlights of Alkem’s Anti-infective portfolio are
- CLAVAM, TAXIM-O, TAXIM, PIPZO, MEROSURE, ZAXTER, SWICH, XONE & XONE-XP,the pillar brands of Alkem in anti-infective are the key contributors to Indian Pharmaceutical Market.
- Redefined paediatric infection management with launch of Merosure-O DS (Feropenem)
* MAT March 2022
